The combination of gefitinib and RAD001 inhibits growth of HER2 overexpressing breast cancer cells and tumors irrespective of trastuzumab sensitivity

por Dragowska, Wieslawa H, Weppler, Sherry A, Qadir, Mohammed A, Wong, Ling Yan, Franssen, Yannick, Baker, Jennifer HE, Kapanen, Anita I, Kierkels, Guido JJ, Masin, Dana, Minchinton, Andrew I, Gelmon, Karen A, Bally, Marcel B
Publicado 2011

Loss of the Notch effector RBPJ promotes tumorigenesis

por Kulic, Iva, Robertson, Gordon, Chang, Linda, Baker, Jennifer H.E., Lockwood, William W., Mok, Winnie, Fuller, Megan, Fournier, Michèle, Wong, Nelson, Chou, Vennie, Robinson, Mark D., Chun, Hye-Jung, Gilks, Blake, Kempkes, Bettina, Thomson, Thomas A., Hirst, Martin, Minchinton, Andrew I., Lam, Wan L., Jones, Steven, Marra, Marco, Karsan, Aly
Publicado 2015